PB127 Ultrasound Contrast Agent

· Point Biomedical

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PB127 Ultrasound Contrast Agent, covering 2008-04-25 to 2008-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease [Phase 3]

See pricing